Serum Institute of India Private Limited

Serum Institute of India Private Limited, established by Dr. Cyrus Poonawalla in 1966, is a leading vaccine manufacturer in the world, with a remarkable production capacity by volume. Headquartered in Pune, India, the company is engaged in producing vaccines for a wide range of diseases, including polio, measles, tetanus, diphtheria, hepatitis B, and COVID-19. The company exports its products to more than 170 countries worldwide, generating a revenue of approximately INR 25,000 crores in 2022.

The company boasts a cutting-edge manufacturing facility that has the capacity to produce over 1.5 billion doses of vaccines annually. Additionally, the company's research and development center is dedicated to discovering new and improved vaccines for emerging and neglected diseases. The company is committed to providing affordable and accessible vaccines to all, especially to low- and middle-income countries.

In the global fight against COVID-19, Serum Institute of India Private Limited has played a crucial role, the company has shown its commitment to the well-being of humanity by producing vaccines that are essential in the fight against the pandemic. It has partnered with AstraZeneca, Novavax, and Codagenix to produce and distribute its COVID-19 vaccines under the brand names Covishield, Covovax, and Covigenix respectively. It has also donated millions of doses of Covishield to the COVAX facility, which aims to ensure equitable access to COVID-19 vaccines for all countries.

Foundation: 1966

Headquarters: Pune, Maharashtra

Website: https://www.seruminstitute.com/